Silver Book Fact

AFib prevalence projected to double by 2050

By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.

Go, AS, EM Hylek, KA Phillips, Y Chang, LE Henault, JV Selby, and DE Singer. Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke preventionâ??the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18): 2370-5. http://jama.ama-assn.org/content/285/18/2370.abstract

Reference

Title
Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke preventionâ??the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Publication
JAMA
Publication Date
2001
Authors
Go, AS, EM Hylek, KA Phillips, Y Chang, LE Henault, JV Selby, and DE Singer
Volume & Issue
Volume 285, Issue 18
Pages
2370-5
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • Annual direct cost of Afib
    Average annual cost comparison between patients with and without atrial fibrillation  
  • Atrial fibrillation prevalence doubles with age
    Atrial fibrillation prevalence doubles with each decade of age—reaching close to 9% by age 80.  
  • Atrial fibrillation as a contributory cause of death
    Around 84% of all deaths with atrial fibrillation as a contributory cause are in individuals age 75 and older.  
  • Average length of stay for major bleeding complications
    The average length of stay for major bleeding complications is six days.  
  • AFib treatment costs, 2001
    In 2001, the estimated treatment costs of atrial fibrillation were $6.65 billion per year—this included hospitalization costs, in- and out-patient care, and medications. This did not include costs of stroke…